Back to mobile site

Melius on SLB (SLB): 'Short-Term Pain, Long-Cycle Gain'

April 24, 2026 1:32 PM EDT Send to a Friend
Melius analyst James West reiterated a Buy rating and $70.00 price target on SLB (NYSE: SLB).The analyst comments "We continue ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login